BioRestorative Therapies delays Q2 10-Q filing after CEO, CFO resignationsPUBT·Aug 14 at 03:32 PMBRTX0.00%
BioRestorative Therapies director Esha Randhawa files initial beneficial ownership statementPUBT·Jul 30 at 05:55 PMBRTX0.00%
BioRestorative Therapies files Form 3 initial beneficial ownership statement for director Steven Collier BrownPUBT·Jul 24 at 02:03 PMBRTX0.00%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Jul 8 at 04:05 PMAPVO-0.36%BRTX0.00%
BioRestorative completes Phase 2 manufacturing for BRTX-100 lumbar disc disease trial supplyPUBT·Jun 25 at 07:15 AMBRTX0.00%
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform | BRTX Stock NewsStockTitan·Jun 24 at 11:15 PMBRTX0.00%
BioRestorative Therapies files Form 3 for director Jatinder Dhaliwal, reporting no beneficial ownershipPUBT·Jun 18 at 11:40 AMBRTX0.00%
Zachary Smith appointed VP of Biocosmeceuticals at BioRestorative Therapies to drive growth and expansion.Unusual Whales·Jun 18 at 07:16 AMBRTX0.00%
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth | BRTX Stock NewsStockTitan·Jun 17 at 11:15 PMBRTX0.00%
BioRestorative Therapies director Katharyn Field files initial beneficial ownership statementPUBT·Jun 17 at 04:02 PMBRTX0.00%
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Jun 4 at 04:05 PMINDP-2.39%BGMS-2.52%
